EAVI2020 EAVI2020 on Twitter EAVI2020 on LinkedIn

HIV Vaccine symposium with EAVI2020’s Prof Robin Shattock and Prof Rogier Sanders

brown building amongst pine trees

UPDATE: this event has been cancelled

Organised by EAVI2020’s very own researcher, Prof Rogier Sanders the HIV Vaccine symposium is taking place in March 2020, Keystone USA. Prof Robin Shattock, coordinator of EAVI2020 will be speaking and focussing on vaccine design and vaccine trials. More information available at the HIV Vaccine webpage.

The abstract deadline for short talks has passed however abstracts may be submitted for poster presentations up to 6 weeks prior to meeting start date based on availability.

HIV Vaccine will be run jointly with HIV Pathogenesis Cure, which will provide the opportunity for investigators to share their expertise and have purposeful discussions on therapeutic vaccination strategies.

Read on for the symposium synopsis and program.

Development of effective prophylactic human immunodeficiency virus (HIV) vaccines are still urgently needed to halt the spread of the HIV/AIDS pandemic. However, development of these vaccines has proven to be a challenge that, despite intensive research efforts over the last 30 years, science has failed to surmount. Nevertheless, the prospects for an effective HIV vaccine have recently been transformed by a series of advances in science. These advances suggest that induction of broadly-reactive antibodies that confer protection via neutralization and/or neutralization-independent mechanisms and elicitation of cytotoxic (CD8) T cell responses can potentially eradicate the virus early after transmission and may ultimately prove to be achievable goals for drug development. This conference will bring together interdisciplinary investigators whose complementary expertise will synergize to inform HIV vaccine design and evaluation to discuss progress and outstanding challenges in areas such as: 1) The design of immunogens and strategies for optimization of germinal center responses to elicit HIV-1 broadly neutralizing antibodies; 2) Identifying prospects for harnessing other antibody effector functions to confer protection; 3) Developing approaches for eliciting rapidly-acting, efficacious HIV-specific CD8 T cell responses; and 4) How to use novel technologies, animal model systems and small-scale clinical trials to inform vaccine development efforts. This conference is being held jointly with HIV Pathogenesis and Cure. This pairing will provide an opportunity for interaction between investigators working in these related areas, and for joint discussion of therapeutic vaccination strategies.

HIV vaccine program


Keystone Symposia

Keystone Symposia on Molecular and Cellular Biology is a 501(c)(3) nonprofit organization headquartered in Silverthorne, Colorado, USA that convenes approximately 50-60 open, peer-reviewed conferences annually, across diverse life-science topics. Subjects bridge basic and clinical research, across academic, industry and global health sectors, to promote translational advances with medical impacts (‘About’, Keystone website).

Latest Posts

World AIDS Day 2022
December 1, 2022
Predicting vaccine…
November 9, 2022
graphic illustration of red blood cells around a HIV virus cell
The Quest for an HIV…
June 24, 2022